Agaricus Muscarius Pellet
Product Images NDC 15631-0010

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Agaricus Muscarius (NDC 15631-0010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0010

This is a description of a homoeopathic medication with the active ingredient Agaricus Muscarius used for temporary relief of headache. The medication is in pellet form and is to be taken orally as directed by a physician. The medication is not recommended for children under 2 years of age. The container has 100 pellets and should be kept in a cool, dark place. The text also indicates important usage information such as not to use if the capsule is broken, and to seek professional advice if symptoms do not improve in four days or worsen. The text includes information about the NDC, batch number, manufacturing, and expiration date of the medication.*

FDA Label Image

Mini Labels Pellets Fda15631 0010

This is a description of a medication that is used for temporary relief of headaches. The active ingredient is not specified but it is compounded with sucrose. The medication is taken orally as directed by a physician, with adults advised to take four or more pellets. Children aged two years and older are advised to take half of the adult dose. The medication label includes the manufacturer date, expiration date, and a unique product number. The medication is available in blister packs.*

FDA Label Image

Rxhomeo Secondary Packing Blister Pack

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

This is a description of a single homeopathic remedy that is lactose-free, manufactured in India by Rihomeo Private Limited, and distributed by Rehomeo, Inc in the US. The product should only be used for specific conditions and if symptoms do not improve or worsen in four days, users should seek assistance from a health professional. The label warns pregnant women and nursing mothers to seek advice before taking the remedy, and to keep the medication out of reach of children. No other information is available from the text provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.